DK409775A - Fremgangsmade til fremstilling af peptider - Google Patents

Fremgangsmade til fremstilling af peptider

Info

Publication number
DK409775A
DK409775A DK409775A DK409775A DK409775A DK 409775 A DK409775 A DK 409775A DK 409775 A DK409775 A DK 409775A DK 409775 A DK409775 A DK 409775A DK 409775 A DK409775 A DK 409775A
Authority
DK
Denmark
Prior art keywords
procedure
preparing peptides
peptides
preparing
Prior art date
Application number
DK409775A
Other languages
Danish (da)
English (en)
Inventor
J L Hughes
J K Seyler
R C-H Liu
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma filed Critical Armour Pharma
Publication of DK409775A publication Critical patent/DK409775A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/067—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for sulfur-containing functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK409775A 1974-09-12 1975-09-12 Fremgangsmade til fremstilling af peptider DK409775A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US505344A US3929758A (en) 1974-09-12 1974-09-12 Cyclization of cysteine-containing peptides

Publications (1)

Publication Number Publication Date
DK409775A true DK409775A (da) 1976-03-13

Family

ID=24009941

Family Applications (1)

Application Number Title Priority Date Filing Date
DK409775A DK409775A (da) 1974-09-12 1975-09-12 Fremgangsmade til fremstilling af peptider

Country Status (16)

Country Link
US (1) US3929758A (fr)
JP (1) JPS5833864B2 (fr)
AU (1) AU498757B2 (fr)
BE (1) BE833336A (fr)
CA (1) CA1045117A (fr)
DE (1) DE2540780A1 (fr)
DK (1) DK409775A (fr)
ES (1) ES440922A1 (fr)
FR (1) FR2284591A1 (fr)
GB (1) GB1527252A (fr)
HU (1) HU175202B (fr)
IT (1) IT1042496B (fr)
LU (1) LU73386A1 (fr)
NL (1) NL179909C (fr)
SU (1) SU849998A3 (fr)
YU (1) YU39747B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4033940A (en) * 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US4066634A (en) * 1976-08-31 1978-01-03 American Home Products Corporation Purification of synthetic somatostatin
US4304692A (en) * 1978-07-24 1981-12-08 Armour Pharmaceutical Company Synthesis of biologically active peptides
US4212795A (en) * 1978-11-13 1980-07-15 Armour Pharmaceutical Company Cyclization of peptides
US4401593A (en) * 1982-02-12 1983-08-30 Armour Pharmaceutical Company Glycine - 8 calcitonin
US4391747A (en) * 1982-02-12 1983-07-05 Armour Pharmaceutical Company Des asparagine-3-calcitonin
US4397780A (en) * 1982-02-12 1983-08-09 Armour Pharmaceutical Company Leucine22 -calcitonin
US4388235A (en) * 1982-02-12 1983-06-14 Armour Pharmaceutical Company Synthesis of peptides
US4469632A (en) * 1982-09-24 1984-09-04 Armour Pharmaceutical Company D-Arginine24 calcitonin
US4444681A (en) * 1982-09-24 1984-04-24 Armour Pharmaceutical Company L-Tyrosine21 calcitonin
US4451395A (en) * 1982-11-08 1984-05-29 Armour Pharmaceutical Company Des-serine2 -des-tyrosine22 calcitonin
JPS60500054A (ja) * 1983-02-15 1985-01-17 ア−マ−・フア−マシユ−テイカル・カンパニ− デス−アスパラギン−３−カルシトニン
WO1984003280A1 (fr) * 1983-02-15 1984-08-30 Armour Pharma Glycine-8-calcitonine
US4549986A (en) * 1983-12-23 1985-10-29 The Salk Institute For Biological Studies Human CGRP
US4623716A (en) 1984-11-01 1986-11-18 Usv Pharmaceutical Corp. Process for the preparation and purification of peptides
JPH0517511Y2 (fr) * 1985-09-30 1993-05-11
US4644054A (en) * 1985-10-01 1987-02-17 Kempe Tomas G Calcitonin analogs with amino acid substituents at position 31
US4658014A (en) * 1985-12-20 1987-04-14 Kempe Tomas G Synthetic peptides with calcitonin-like activity
US4687839A (en) * 1985-12-23 1987-08-18 Kempe Tomas G Calcitonin gene related peptide analogs with C-terminal D-amino acid substituents
US4697002A (en) * 1985-12-23 1987-09-29 Kempe Tomas G Calcitonin gene related peptide analogs with amino acid subdstituents at the penultimate position 36
US4820804A (en) * 1987-04-21 1989-04-11 Rorer Pharmaceutical Corporation Analogs of [1,7-di-alanine, des-19-leucine]calcitonin
US4824936A (en) * 1987-05-06 1989-04-25 Rorer Pharmaceutical Corporation (19-Alanine) calcitonin
JP2682061B2 (ja) * 1988-10-07 1997-11-26 藤沢薬品工業株式会社 ペプチドの分子内ジスルフィド結合の形成法
ES2051647B1 (es) * 1992-12-10 1995-01-16 Lipotec Sa Procedimiento para la preparacion de calcitonina de salmon.
US5674850A (en) * 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
NZ268442A (en) * 1993-06-29 1996-09-25 Ferring Bv Aqueous composition of desmopressin for nasal spray administration
WO1995001368A1 (fr) * 1993-06-29 1995-01-12 Ferring B.V. Synthese amelioree de peptides cycliques
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
SE9400918L (sv) * 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
EP1452868A2 (fr) 2003-02-27 2004-09-01 Pepscan Systems B.V. Procédé pour sélectionner un médicament d'intérêt potentiel
US7723474B2 (en) * 2003-10-21 2010-05-25 The Regents Of The University Of California Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies
WO2008077621A1 (fr) * 2006-12-23 2008-07-03 Aplagen Gmbh Procédé de formation de ponts disulfure
US20140086895A1 (en) 2011-05-10 2014-03-27 Universite De Rouen Methods and pharmaceutical compositions for the treatment of autoimmune diseases
GB201313352D0 (en) 2013-07-26 2013-09-11 Isis Innovation Identification of peptide ligands
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
WO2016184784A1 (fr) 2015-05-15 2016-11-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Peptides comprenant le domaine de liaison des protéines de plasmodium falciparum (cbp1 et cbp2) à cx3cl1 de chimiokine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3560521A (en) * 1967-08-07 1971-02-02 Merck & Co Inc Blocking groups for cysteine containing peptides
US3679655A (en) * 1968-06-28 1972-07-25 Hoechst Ag N,n-disubstituted aminoethylcarbamyl protecting groups for cysteine
US3849388A (en) * 1968-10-15 1974-11-19 Ciba Geigy Corp Analogues of human thyrocalcitonin
DE1950711A1 (de) * 1968-10-15 1970-04-30 Ciba Geigy Neue Peptide und Verfahren zu ihrer Herstellung
GB1294771A (en) * 1969-01-31 1972-11-01 Sandoz Ltd Thyrocalcitonin derivative
CH523868A (de) * 1969-10-22 1972-06-15 Ciba Geigy Ag Verfahren zur Herstellung neuer Dotriacontapeptidamide und ihrer Derivate
US3801561A (en) * 1970-10-29 1974-04-02 Sandoz Ltd Derivatives of salmon thyrocalcitonin
ZA723287B (en) * 1971-06-18 1973-02-28 Hoffmann La Roche Nonapeptides and processes for the preparation thereof
BE785933A (fr) * 1971-07-07 1973-01-08 Ciba Geigy Procede de preparation de peptides contenant de la cystine

Also Published As

Publication number Publication date
JPS5833864B2 (ja) 1983-07-22
YU230075A (en) 1982-02-28
HU175202B (hu) 1980-06-28
LU73386A1 (fr) 1976-04-13
DE2540780A1 (de) 1976-04-01
AU8473775A (en) 1977-03-17
AU498757B2 (en) 1979-03-22
US3929758A (en) 1975-12-30
FR2284591B1 (fr) 1978-12-01
JPS5156448A (fr) 1976-05-18
CA1045117A (fr) 1978-12-26
YU39747B (en) 1985-04-30
DE2540780C2 (fr) 1989-05-24
GB1527252A (en) 1978-10-04
FR2284591A1 (fr) 1976-04-09
IT1042496B (it) 1980-01-30
SU849998A3 (ru) 1981-07-23
NL179909C (nl) 1986-12-01
BE833336A (fr) 1975-12-31
ES440922A1 (es) 1977-06-16
NL7510761A (nl) 1976-03-16

Similar Documents

Publication Publication Date Title
DK409775A (da) Fremgangsmade til fremstilling af peptider
DK487475A (da) Fremgangsmade til fremstilling af vandkveldende polyalkylenoxid
DK29576A (da) Fremgangsmade til fremstilling af peptider
DK392675A (da) Fremgangsmade til fremstilling af substituerede puriner
DK349875A (da) Fremgangsmade til fremstilling af betonkonstruktioner
DK222375A (da) Fremgangsmade til fremstilling af alkyl-tert-butylethere
DK33177A (da) Fremgangsmade til fremstilling af peptider
DK158614C (da) Fremgangsmaade til fremstilling af et dihalogenvinylcyclopropancarboxylat
DK151814C (da) Fremgangsmaade til fremstilling af polyvinylpyrrolidon-iod
DK558975A (da) Fremgangsmade til fremstilling af polycarbonater
DK463775A (da) Fremgangsmade til fremstilling af dipeptidderivater
DK551276A (da) Fremgangsmade til fremstilling af peptidcarbazater
DK292475A (da) Fremgangsmade til fremstilling af derivater af 3-amino-2-hydroxy-1-phenoxy-propan
DK351875A (da) Fremgangsmade til fremstilling af 7-methoxy-6-thiatetracyliner
DK223175A (da) Fremgangsmade til fremstilling af pyridobenzodiazepinoner
DK247175A (da) Fremgangsmade til fremstilling af decahydroisoquinolin-forbindelser
DK145877C (da) Fremgangsmaade til fremstilling af alfa-6-desoxy-5-hydroxytetracyclin
DK442977A (da) Fremgangsmade til fremstilling af gamma-l-glutamyltaurin
DK154890C (da) Fremgangsmaade til fremstilling af 7beta-acylamino-7alfa-alkoxycephalosporiner
DK547675A (da) Fremgangsmade til fremstilling af 6-methyl-8beta-substituerede methylergoliner
DK197575A (da) Fremgangsmade til fremstilling af peptider
DK373475A (da) Fremgangsmade til optrekning af daser
DK137539B (da) Fremgangsmade til fremstilling af 11beta-fluor-4-androsten-3-oner
DK482675A (da) Fremgangsmade til fremstilling af antibakterielt aktive forbindelser
DK505275A (da) Fremgangsmade til fremstilling af 7,7-diphenylhexahydro-1,4-oxazepiner

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment